United States
Germany
Japan
United Kingdom
China
Antibodies
HCoV-OC43 Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus OC43 |
| Modifications | Unmodified |
HCoV-OC43 Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus OC43 |
| Modifications | Unmodified |
HCoV-NL63 Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus NL63 |
| Modifications | Unmodified |
HCoV-229E Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus 229E |
| Modifications | Unmodified |
HCoV-HKU1 Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus HKU1 |
| Modifications | Unmodified |
HCoV-HKU1 Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus HKU1 |
| Modifications | Unmodified |
HCoV-229E Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus 229E |
| Modifications | Unmodified |
SARS-CoV Spike Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Modifications | Unmodified |
SARS-CoV Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Modifications | Unmodified |
SARS-CoV Spike RBD Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Modifications | Unmodified |
